Recombinant Human COX7A2L Protein ，GST

COX7A2L, a member of the cytochrome c oxidase (COX) subunit family, plays a crucial role in mitochondrial respiration and energy production. Its involvement in the COX complex, which is the terminal enzyme of the mitochondrial electron transport chain, underscores its importance in cellular metabolism. Research into COX7A2L is motivated by its potential implications in a variety of biological processes and diseases, particularly those related to mitochondrial dysfunction. Abnormalities in COX function have been associated with neurodegenerative diseases, metabolic disorders, and ischemic conditions. As such, understanding the structure-function relationship of COX7A2L is critical for elucidating its role in these pathological states. Recombinant expression of COX7A2L facilitates detailed studies of its biochemical properties and interaction with other mitochondrial components, enabling researchers to investigate how variations in this protein may contribute to disease mechanisms. Furthermore, the generation of recombinant COX7A2L allows for potential therapeutic applications, including the development of strategies aimed at enhancing mitochondrial function in conditions resulting from oxidative stress or impaired energy metabolism. By exploring the properties and functions of this protein, researchers hope to pave the way for novel treatments targeting mitochondrial-related diseases, improving our understanding of their etiology and progression.